Revenue
2023
2024
2025
BridgeBio Oncology Therapeutics, Inc. (BBOT)
Price$8.94Cached quote
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Research & development | $121.2M | $73.1M | $56.3M |
| Operating expenses | $145.8M | $80.9M | $64.8M |
| Operating income | −$145.8M | −$80.9M | −$41,692 |
| EBITDA | −$145.2M | −$80.7M | −$64.7M |
| Net income | −$134.0M | −$74.3M | −$41,692 |
| Basic EPSper basic share | -$4.30 | -$5,756.41 | -$0.82 |
| Diluted EPSper diluted share | -$4.30 | -$5,756.41 | -$0.82 |
Owners
Reported shareholders
22.32%of listed shares
Cormorant Asset Management, LP17.88M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Cormorant Asset Management, LP | 22.32%17.88M shares |
DEERFIELD MANAGEMENT COMPANY, L.P. | 6.10%4.89M shares |
Omega Fund Management, LLC | 4.11%3.29M shares |
EcoR1 Capital, LLC | 3.52%2.82M shares |
Alphabet Inc. | 3.52%2.82M shares |
WELLINGTON MANAGEMENT GROUP LLP | 3.48%2.79M shares |
ENAVATE SCIENCES GP, LLC | 3.28%2.63M shares |
CITADEL ADVISORS LLC | 3.27%2.62M shares |
NOVO HOLDINGS A/S | 2.81%2.25M shares |
BlackRock, Inc. | 2.69%2.15M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 2.50%2.01M shares |
Laurion Capital Management LP | 2.50%2M shares |
ARMISTICE CAPITAL, LLC | 2.20%1.76M shares |
STATE STREET CORP | 1.29%1.04M shares |
Aisling Capital Management LP | 1.27%1.02M shares |
Opaleye Management Inc. | 0.87%700K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.78%622.35K shares |
Granahan Investment Management, LLC | 0.70%558.53K shares |
SPHERA FUNDS MANAGEMENT LTD. | 0.58%460.99K shares |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.50%400K shares |
Percentages use 80.12M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data